Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.

Byrne CD.

Proc Nutr Soc. 2013 Nov;72(4):412-9. doi: 10.1017/S0029665113001249. Epub 2013 May 14. Review.

PMID:
23668723
2.

Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.

Byrne CD.

Diabet Med. 2012 Sep;29(9):1098-107. doi: 10.1111/j.1464-5491.2012.03732.x. Review.

PMID:
22672330
3.

Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments.

Scorletti E, Calder PC, Byrne CD.

Endocrine. 2011 Dec;40(3):332-43. doi: 10.1007/s12020-011-9530-x. Epub 2011 Sep 6. Review.

PMID:
21894514
4.

Non-alcoholic fatty liver disease: an emerging pathological spectrum.

Zafrani ES.

Virchows Arch. 2004 Jan;444(1):3-12. Epub 2003 Dec 18. Review.

PMID:
14685853
5.

Insulin resistance in nonalcoholic fatty liver disease.

Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G.

Curr Pharm Des. 2010 Jun;16(17):1941-51. Review.

PMID:
20370677
6.

Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.

Byrne CD, Targher G.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1155-61. doi: 10.1161/ATVBAHA.114.303034. Epub 2014 Apr 17. Review.

7.

[Non-alcoholic fatty liver disease--new view].

Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.

Pol Merkur Lekarski. 2008 Jun;24(144):568-71. Review. Polish.

PMID:
18702346
8.

The central role of the non alcoholic fatty liver disease in metabolic syndrome.

Hurjui DM, Niţă O, Graur LI, Mihalache L, Popescu DS, Graur M.

Rev Med Chir Soc Med Nat Iasi. 2012 Apr-Jun;116(2):425-31.

PMID:
23077931
9.

Epidemiology and natural history of patients with NAFLD.

Bhala N, Jouness RI, Bugianesi E.

Curr Pharm Des. 2013;19(29):5169-76. Review.

PMID:
23394091
10.

Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk?

Montecucco F, Mach F.

Endocr Metab Immune Disord Drug Targets. 2008 Dec;8(4):301-7. Review.

PMID:
19075784
11.

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Anstee QM, Targher G, Day CP.

Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44. doi: 10.1038/nrgastro.2013.41. Epub 2013 Mar 19. Review.

PMID:
23507799
12.

The epidemiology of nonalcoholic fatty liver disease in adults.

Clark JM.

J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S5-10. Review.

PMID:
16540768
13.

Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.

Fan JG.

J Dig Dis. 2008 May;9(2):63-7. doi: 10.1111/j.1751-2980.2008.00323.x. Review.

PMID:
18419637
14.

Non-alcoholic fatty liver disease and cardiovascular risk.

Brea A, Puzo J.

Int J Cardiol. 2013 Aug 20;167(4):1109-17. doi: 10.1016/j.ijcard.2012.09.085. Epub 2012 Nov 9. Review.

PMID:
23141876
15.

Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients.

Mikolasevic I, Racki S, Zaputovic L, Lukenda V, Milic S, Orlic L.

Med Hypotheses. 2014 Feb;82(2):205-8. doi: 10.1016/j.mehy.2013.11.039. Epub 2013 Dec 8.

PMID:
24365277
16.

Recent concepts in non-alcoholic fatty liver disease.

Adams LA, Angulo P.

Diabet Med. 2005 Sep;22(9):1129-33. Review.

PMID:
16108837
17.

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?

Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A; Asia-Pacific Working Party for NAFLD.

J Gastroenterol Hepatol. 2007 Jun;22(6):794-800. Epub 2007 May 13.

PMID:
17498218
18.

Metabolic disturbances in non-alcoholic fatty liver disease.

Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.

Clin Sci (Lond). 2009 Apr;116(7):539-64. doi: 10.1042/CS20080253. Review.

PMID:
19243311
19.
20.

Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.

Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C.

World J Gastroenterol. 2011 Jul 14;17(26):3082-91. doi: 10.3748/wjg.v17.i26.3082. Review.

Items per page

Supplemental Content

Write to the Help Desk